Perspective on antigen processing and presentation

Immunological Reviews

Volumn 185, Issue , 2002, Pages 86-102

  Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; HUMAN; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-ANTIBODY COMPLEX; ANTIGEN-PRESENTING CELLS; ANTIGENS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; LYMPHOCYTES; MACROPHAGES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION;

EID: 0036631027     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2002.18510.x     Document Type: Review

References (136)

1. The regulatory role of macrophages in antigenic stimulation. Part two. Symbiotic relationship between lymphocytes and macrophages
2. The Croonian lecture on immunity with special reference to cell life
3. Fortsetzung der mitteilungen uber ein heilmittel gegen tuberkulose
4. Cellular immunity
5. The cellular transfer of cutaneous hypersensitivity to tuberculin
6. Modification of Jerne's theory of antibody production using the concept of clonal selection
7. Immunological function of the thymus
8. Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes
9. The failure of thymus-derived cells to produce antibody
10. Thymus-marrow cell combinations. Synergism in antibody production
11. Cell selection by antigen in the immune response
12. Variations in affinities of antibodies during the immune response
13. Binding of radioiodinated bovine serum albumin to mouse spleen cells
14. Antigenicity: Some molecular aspects
15. Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins
16. A third type of murine T-cell receptor gene
17. A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes
18. Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice
19. Studies on artificial antigens. III. The genetic control of the immune response to hapten poly-L-lysine conjugates in guinea pigs
20. Studies on hypersensitivity to denatured proteins in guinea pigs
21. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation
22. Immune responses against native and chemically modified albumins in mice
23. Presence of specific determinants for T cell in denatured antigen and polypeptide chains
24. Antigen recognition by T cells and B cells: Recognition of cross-reactivity between native and denatured forms of globular antigens
25. Genetic control of the antibody response, relationship between immune response and histocompatibility (H-2) type
26. Role of MHC gene products in immune regulation
27. Activity of sensitized thymus-derived lymphocytes in lymphocytic choriomeningitis reflects immunological surveillance against altered self components
28. Cell interactions between histoincompatible T and B lymphocytes. IV. Involvement of immune response (Ir) gene control of lymphocyte interaction controlled by the gene
29. H-2 dependence of co-operation between T and B cells in vivo
30. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes
31. Determinant selection is a macrophage dependent immune response gene function
32. Acquired immunological tolerance to a fraction of bovine gamma globulin
33. Biography of a tolerant state: Cellular parameters of the unresponsive state induced in adult mice to human gamma globulin
34. Role of macrophages in the immune response
35. The immune response of mice to antigen in macrophages
36. Persistence of immunogenicity of antigen after uptake by macrophages
37. The specific binding of Listeria monocytogenes-immune T lymphocytes to macrophages. I. Quantitation and role of H-2 gene products
38. Role of nominal antigen and Ia antigen in the binding of antigen-specific T lymphocytes to macrophages
39. Dendritic cells are crucial accessory cells for thymus-dependent antibody responses in mouse and man
40. Dendritic cells and the control of immunity
41. Requirements for the processing of antigens by antigen-presenting B cells. I. Functional comparison of B cell tumors and macrophages
42. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes
43. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells
44. Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridoma
45. Processing of lysozyme by macrophages: Identification of the determinant recognized by two T cell hybridomas
46. Immunological focusing by the mouse major histocompatibility comlex: Mouse strains confronted with distantly related lysozymes confine their attention to very few epitopes
47. Serendipity in immunology
48. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing
49. The handling of Listeria monocytogenes by macrophages: The search for an immunogenic molecule in antigen presentation
50. k
51. Binding of immunogenic peptides to Ia histocompatibilty molecules
52. Antigenic competition at the level of peptide-Ia binding
53. Binding to Ia protects an immunogenic peptide from proteolytic degradation
54. Two structural states of complexes or peptide and class II major histocompatibility complex revealed by photoaffinity-labeled peptides
55. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding
56. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules
57. Interaction between a 'processed' ovalbumin peptide and Ia molecules
58. The relationship between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides
59. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
60. The foreign antigen binding site and T cell recognition regions of class I histocompatibility regions
61. Structure of the human class I histocompatibility antigen HLA-A2
62. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope
63. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells
64. b
65. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation
66. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an antigenic peptide from influenza virus
67. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen
68. X-ray crystal structure of HLA-DR4 (DRA*0101 DRB1*0401) complexed with a peptide from human collagen II
69. d-peptide complexes reveal that high affinity can be achieved without large anchor residues
70. k in complex with a dominant epitope of lysozyme
71. g7 and autoimmune diabetes
72. Structural basis of peptide binding and presentation by the type 1 diabetes-associated MHC class II molecule of NOD mice
73. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen
74. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2
75. The crystal structure of a T cell receptor in complex with peptide and MHC class II
76. T cell receptor-MHC interactions up close
77. Assembly, transport, and function of MHC class II molecules
78. The cell biology of antigen presentation
79. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation
80. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells
81. Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action
82. Defective antigen processing in GILT-free mice
83. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route
84. Distinct antigen MHC class II complexes generated by separate processing pathways
85. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules
86. MHC ligands and peptide motifs: First listing
87. Sequence analysis of peptides bound to MHC class II molecules
88. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size
89. d
90. Minute quantities of a single dominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules
91. Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules
92. k by using peptide-specific immunoaffinity
93. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry
94. k molecules of two epitopes found in tandem in an extended polypeptide
95. k histocompatibility molecules
96. Quantitation of lysozyme peptides bound to class II MHC molecules indicates very large differences in levels of presentation
97. g7 molecule are unique and determined by the amino acid changes in the P9 pocket
98. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses
99. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis
100. Processing pathways for presentation of cytosolic antigen to MHC class-II restricted T cells
101. Class-II restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells
102. k
103. Peptide binding to HLA-DR1: A simple polyalanine peptide retains MHC binding
104. k molecule
105. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition
106. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions
107. k class II molecules
108. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell
109. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage
110. Insulin-dependent diabetes mellitus
111. The first external domain of the nonobese diabetic mouse class II, I-A beta chain is unique
112. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: A family study
113. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes
114. g7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus
115. Negative selection of immature thymocytes by a few peptide-MHC complexes: Differential sensitivity of immature and mature T cells
116. Quantitative aspects of the T cell repertoire that escapes negative selection
117. Determination of the relationship between T cell responsiveness and the number of MHC-peptide complexes using specific monoclonal antibodies
118. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation
119. The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells
120. Genes and antibodies
121. + T cells
122. The level of peptide-MHC complex determines the susceptibility to autoimmune diabetes: Studies in HEL transgenic mice
123. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes
124. Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice
125. + T cell response to a model antigen
126. Dominance and crypticity of T cell antigenic determinants
127. Coordinate regulation of complex T cell populations responding to bacterial infection
128. k-restricted determinant of hen egg lysozyme: Limitations of lymph node proliferation studies in defining immunodominance and crypticity
129. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing
130. Deamidation of asparagine in man MHC-bound peptide affects T cell recognition but does not explain type B reactivity
131. Distinct recognition by two subsets of T cells of an MHC-class-II-peptide complex
132. Studies in Listeriosis show the strong symbiosis between the innate cellular system and the T cell response
133. Innate immune recognition